U.S. Wireless Telecom Stock News

Willdan Group (WLDN) shares are reacting to news that the company secured a $31 million design-build contract from Encina Wastewater Authority for a renewable biogas cogeneration and on-site power project in California. See our latest analysis for Willdan Group. The Encina contract arrives at a time when Willdan Group’s 1 day share price return of 1.84% contrasts with a 30 day share price decline of 24.59%. Its 3 year total shareholder return of about 2.8x points to strong longer term...

Trulieve Cannabis (TRLV) has drawn fresh investor attention after celebrating Georgia’s expanded medical cannabis program with its first product sales in Marietta, while also reshaping its finance leadership and trading on the New York Stock Exchange. See our latest analysis for Trulieve Cannabis. Despite the Georgia rollout and NYSE listing increasing visibility, Trulieve Cannabis’ share price has been choppy, with a 30 day share price return down 12.47%, a 90 day share price return up...

Recent demand trends and event backdrop for Trane Technologies Recent strength in Trane Technologies (TT) stock has been closely tied to rising demand for its energy-efficient HVAC solutions and a sharp pick up in commercial bookings, particularly across the Americas region. See our latest analysis for Trane Technologies. At a latest share price of $480.2, Trane Technologies has paired a 20.65% year to date share price return with a 10.91% 1 year total shareholder return. Its 3 year total...

FB Financial (FBK) opened Q2 2026 with total revenue of US$164.6 million and basic EPS of US$1.14, putting a clear spotlight on how the bank is currently turning its lending and fee income into bottom line results. Over the last few quarters, revenue has moved from US$71.5 million in Q2 2025 to US$164.6 million in Q2 2026, while basic EPS has increased from US$0.06 to US$1.14, giving investors a clearer view of how the income statement has scaled. With a net profit margin of 30.2% over the...

Investors just watched IBM drop 25% after reporting 1% revenue growth against a 5% forecast, and the message is hard to miss: budgets are being pulled away from parts of traditional IT and pushed toward AI infrastructure hardware. That shift is unsettling for some software and device stocks, but it could concentrate attention on companies that build the chips, memory and data center hardware behind AI. This article walks through 3 stocks from an AI infrastructure hardware screener that appear...

Cohen & Steers recently reported quarterly results after the market close, following a period in which analysts had anticipated 11% year-on-year revenue growth. This earnings release drew particular attention because the firm had previously missed Wall Street revenue estimates multiple times over the last two years, raising questions about whether execution is improving. We’ll now examine how the upcoming earnings report and debate over continued revenue growth could influence Cohen &...

Earlier this week, Teva, a division of Deckers Brands, released its Fall 2026 lineup, headlined by the athlete-co-created Trailpeak trail running shoe and new styles across the Aventrail, Hurricane, ReEmber, and lifestyle ranges. This push deeper into technical trail, road-to-trail, and lifestyle footwear highlights how Deckers is using Teva to complement HOKA and UGG by broadening its reach across performance and everyday outdoor use. We’ll now explore how Teva’s athlete-driven Trailpeak...

Why Marqeta Stock Is Back On Investors’ Radar Marqeta (MQ) drew fresh attention after a 4.5% move higher, as investors rotated from AI chip stocks into enterprise software and payments platforms tied to AI monetization. See our latest analysis for Marqeta. Beyond today’s move, Marqeta’s share price return shows a short burst of momentum, with a 7-day share price return of 12.5% and a 30-day share price return of 11.63%, set against a year-to-date share price decline of 6.41% and a 1-year...

Hyatt Hotels (NYSE:H) and Air Canada’s Aeroplan launched a new partnership that links their loyalty programs. World of Hyatt and Aeroplan members can now connect accounts to broaden reward earning and redemption options. The collaboration introduces new ways to progress toward elite status across both travel programs. Hyatt Hotels, trading at $191.0, is adding this airline tie up at a time when the stock is up 30.5% over the past year and 149.6% over five years. The new link with Aeroplan...

In recent days, Seagate Technology Holdings has been pulled lower as a broad selloff in AI and memory chip names followed concerns about cloud spending, inventory buildup, and macro risks such as inflation and Middle East tensions. At the same time, enthusiasm around Seagate’s HAMR‑based Mozaic 4+ drives and its role in AI and cloud storage shows how sector-wide sentiment can temporarily mask company‑specific strengths. With sector worries about cloud capex and inventory now front of mind,...

Equity Residential recently declared a dividend and is preparing to report earnings, focusing investor attention on its apartment portfolio, cash flow, and operating fundamentals. This renewed scrutiny puts a spotlight on how occupancy, rental pricing, resident retention, and financing conditions could influence the REIT’s income profile and perceived resilience. Next, we’ll examine how this increased focus on occupancy and rental pricing interacts with Equity Residential’s existing...

Mueller Water Products has delivered an 80.6% total return over the past five years, yet its current share price of US$24.70 still screens as cheap against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and traditional market multiples. That combination puts the focus on whether the recent moderation in shorter term returns reflects a pause in a longer rerating or a sign that the value case is already well understood. Over five years, Mueller Water Products has returned...

Graham stock has logged a very strong run over the last several years, yet its latest valuation checks suggest the shares are now pricing in a lot of good news rather than standing out as a clear bargain. Over the past 5 years, Graham has delivered a very large total return of about 7x, which sets a high bar for any further upside case. Recent growth momentum and raised expectations for future revenue may support the current share price, but any setback in demand or profitability could...

In the lead‑up to its 21 July earnings release, The Charles Schwab Corporation has drawn attention as Wall Street anticipated year‑over‑year earnings growth on higher revenues for the June 2026 quarter, supported by a more optimistic analyst consensus. An interesting angle is that the Most Accurate Estimate recently moved above the broader Zacks Consensus Estimate, highlighting a late shift in analyst expectations that could influence how investors interpret Schwab’s earnings power. We’ll...

AtaiBeckley stock has delivered a 148.7% return over the last three years, yet its valuation checks flag the shares as expensive rather than a clear bargain. A 148.7% three year return puts AtaiBeckley firmly in the spotlight and raises the bar for what future progress needs to justify the current share price. The advancing psychedelic pipeline, including BPL-003 in Phase 3 and VLS-01 in Phase 2b for treatment resistant depression, can support high expectations, while takeover speculation...

Gap stock has pulled back recently but, on a three year view, the share price is still far ahead of where it was, and the current valuation work suggests the market may be assigning a discount relative to an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and to earnings based multiples. Gap has delivered a 139.2% return over the past three years, which puts the recent weakness into context as a move within a much larger recovery. For valuation, the key swing factor...

Elevance Health (ELV) has completed a long running share repurchase program as investors prepare for an anticipated year over year decline in Q2 earnings and revenue and monitor new institutional interest. See our latest analysis for Elevance Health. At a share price of $426.79, Elevance Health has seen firm upward momentum recently, with a 30 day share price return of 5.62% and a 90 day share price return of 37.15%, while the 1 year total shareholder return of 29.61% sits well ahead of its 3...

The U.S. Small Business Administration recently formalized a new phase of its anti-fraud initiative, rolling out Palantir Technologies’ software to help uncover and prosecute fraud across pandemic-era small business relief programs, while fresh collaborations with Rackspace, SNP, and GNP Seguros extend Palantir’s AI platforms into tightly regulated sectors worldwide. Together, these moves highlight Palantir’s push to become core infrastructure for compliant, operational AI where data...

Helium export curbs put Linde (LIN) in focus Restrictions on helium exports from China, Russia, and Qatar have tightened global supply for semiconductor and AI hardware producers, putting Linde (LIN) in the spotlight as investors reassess helium-exposed stocks. See our latest analysis for Linde. Linde’s share price at US$522.54 has eased in the last week, with a 7 day share price return of 2.92% and a relatively steady 90 day share price return of 4.94%, while the 5 year total shareholder...

McKesson (NYSE:MCK) released its Fiscal Year 2026 Impact Report, outlining progress on sustainability, healthcare delivery, and stakeholder engagement. The report provides updated details on environmental goals, community support programs, and partnerships with healthcare providers. It offers investors and other stakeholders a consolidated view of how the company is approaching ESG topics alongside its core distribution and services business. McKesson enters this update with its stock at...

Check Point Software Technologies stock has had a tough year, with a steep share price decline set against valuation work that points to the shares trading below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and supported by market multiples that also lean cheap. Over the past 12 months, Check Point Software Technologies is down 37.4%, which means any sign of undervaluation matters more for investors trying to assess if sentiment has swung too far. Recent reports...

Cooling US inflation data and sharply lower producer and gasoline prices are reshaping expectations for borrowing costs and consumer budgets, while tensions in the Strait of Hormuz keep the energy outlook uncertain. That mix can reward some U.S. Domestic Consumer Discretionary Stocks exposed to these trends and leave others facing tougher decisions on pricing and costs. This article focuses on three stocks from the screener that appear positively exposed to the recent PPI and CPI moves,...

Why MakeMyTrip Stock Is Back On Investors’ Radar MakeMyTrip (MMYT) has drawn attention after its stock declined 2.33% in the latest session despite broader market gains. Investors are now focused on an upcoming earnings report that is expected to show $0.10 per share. See our latest analysis for MakeMyTrip. The recent 1 day share price decline of 2.33% and 7 day drop of 5.03% come after a 30 day share price return of 29.20%. The 1 year total shareholder return is down 40.06%, while the 5 year...

Why investors are reassessing Humana stock now Recent debate over Humana (HUM) centers on conflicting views of its valuation, with tighter Medicare oversight and compliance concerns set against models that point to undervaluation based on projected future cash flow. See our latest analysis for Humana. Humana’s recent share price strength, including a 7.26% 1 month share price return and 53.80% year to date share price return to about $406.77, contrasts with weaker 3 and 5 year total...